Liver cancer treatment can place significant financial burden on patients, analysis shows

Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.

Related Keywords

United States ,Texas ,Ramit Singal ,Willisc Maddrey ,Emily Henderson ,National Institutes Of Health ,Haroldc Simmons Comprehensive Cancer Center ,Division Of Digestive ,Population Informatics Lab ,Ut Southwestern Medical Center ,Liver Tumor Program ,Research Institute Of Texas ,Internal Medicine ,Liver Diseases ,Comprehensive Cancer Center ,Clinical Gastroenterology ,Medical Director ,Tumor Program ,Dedman Family Scholar ,End Results ,Cancer Prevention ,Research Institute ,National Institutes ,Texas Virtual Data Library ,Cancer ,Cancer Treatment ,Liver ,Liver Cancer ,Medicare ,Cancer Therapy ,Arcinoma ,Cirrhosis ,Fatty Liver ,Astroenterology ,Hepatocellular Carcinoma ,Hepatology ,Liver Disease ,Medicine ,Ortality ,Research ,